Universal definition of loss to follow-up in HIV treatment programs: A statistical analysis of 111 facilities in Africa, Asia, and Latin America

PLoS Medicine

Volumn 8, Issue 10, 2011, Pages

  Chi, Benjamin H ^a,b   Yiannoutsos, Constantin T ^c   Westfall, Andrew O ^a,b   Newman, Jamie E ^d   Zhou, Jialun ^e   Cesar, Carina ^f   Brinkhof, Martin W G ^g   Mwango, Albert ^h   Balestre, Eric ⁱ   Carriquiry, Gabriela ^j   Sirisanthana, Thira ^k   Mukumbi, Henri ^l   Martin, Jeffrey N ^m   Grimsrud, Anna ⁿ   Bacon, Melanie ^o   Thiebaut, Rodolphe ⁱ  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^c INDIANA UNIVERSITY   (United States)

^d RTI INTERNATIONAL   (United States)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f FUNDACIÓN HUÉSPED   (Argentina)

^g UNIVERSITY OF BERN   (Switzerland)

^h MINISTRY OF HEALTH   (Zambia)

ⁱ INSERM   (France)

^j INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^k CHIANG MAI UNIVERSITY   (Thailand)

^l Amo Congo ^*  (Democratic Republic Congo)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ UNIVERSITY OF CAPE TOWN   (South Africa)

^o NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADOLESCENT; AFRICA; ARTICLE; ASIA; CONTROLLED STUDY; DATA ANALYSIS; FOLLOW UP; HEALTH CARE; HEALTH CARE FACILITY; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT CARE; PATIENT CODING; RURAL AREA; SOUTH AND CENTRAL AMERICA; STANDARDIZATION; TREATMENT REFUSAL; URBAN AREA; ADULT; COHORT ANALYSIS; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; NOMENCLATURE; PATIENT COMPLIANCE; STATISTICS;

ADOLESCENT; ADULT; AFRICA; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA; COHORT STUDIES; DELIVERY OF HEALTH CARE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; LATIN AMERICA; LOST TO FOLLOW-UP; PATIENT COMPLIANCE; TERMINOLOGY AS TOPIC;

EID: 80055033631     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001111     Document Type: Article

References (30)

1. Joint United Nations Programme on HIV/AIDS (2009) Towards universal access: scaling up priority HIV/AIDS interventions in the health sector, progress report 2009 Geneva World Health Organization.
2. World Health Organization (2006) Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond, March 2006 Geneva World Health Organization.
3. Rosen S, Fox MP, Gill CJ, (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298 doi:10.1371/journal.pmed.0040298.
4. Fox MP, Rosen S, (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 15 Suppl 1: 1-15.
5. Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, et al. (2010) Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa. Trop Med Int Health 15 (Suppl 1): 34-42.
6. McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, et al. (2007) Cohort profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol 36: 969-976.
7. Dabis F, Balestre E, Braitstein P, Miotti P, Brinkhof WG, et al. (2005) Cohort profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts. Int J Epidemiol 34: 979-986.
8. Chi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, et al. (2010) An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Am J Epidemiol 171: 924-931.
9. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296: 782-793.
10. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, et al. (2007) Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 298: 1888-1899.
11. International Epidemiologic Databases to Evaluate AIDS (2011) Participating regions. International Epidemiologic Databases to Evaluate AIDS. Available: http://www.iedea.org/regions. Accessed 23 September 2011.
12. Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, et al. (2010) Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep 7: 234-244.
13. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86: 559-567.
14. Geng EH, Emenyonu N, Bwana MB, Glidden DV, Martin JN, (2008) Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300: 506-507.
15. Cesar C, Shepherd BE, Krolewiecki AJ, Fink VI, Schechter M, et al. (2010) Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. PLoS ONE 5: e10490 doi:10.1371/journal.pone.0010490.
16. Wools-Kaloustian K, Kimaiyo S, Musick B, Sidle J, Siika A, et al. (2009) The impact of the President's Emergency Plan for AIDS Relief on expansion of HIV care services for adult patients in western Kenya. AIDS 23: 195-201.
17. Wools-Kaloustian K, Kimaiyo S, Diero L, Siika A, Sidle J, et al. (2006) Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 20: 41-48.
18. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824.
19. Tuboi SH, Schechter M, McGowan CC, Cesar C, Krolewiecki A, et al. (2009) Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr 51: 615-623.
20. Falster K, Choi JY, Donovan B, Duncombe C, Mulhall B, et al. (2009) AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment. AIDS 23: 2323-2336.
21. Larson BA, Brennan A, McNamara L, Long L, Rosen S, et al. (2010) Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health 15 (Suppl 1): 43-47.
22. McGuire M, Munyenyembe T, Szumilin E, Heinzelmann A, Le Paih M, et al. (2010) Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health 15 (Suppl 1): 55-62.
23. Holmes CB, Williams-Sherlock MA, Bouey PD, (2009) Monitoring and evaluation of PEPFAR treatment programmes. Lancet 374: 1146-1147.
24. Zambian Ministry of Health (2010) Adult and adolescent antiretroviral therapy protocols Lusaka (Zambia) Printech Press.
25. Brinkhof MW, Pujades-Rodriguez M, Egger M, (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 4: e5790 doi:10.1371/journal.pone.0005790.
26. Yiannoutsos CT, An MW, Frangakis CE, Musick BS, Braitstein P, et al. (2008) Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE 3: e3843 doi:10.1371/journal.pone.0003843.
27. Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, et al. (2011) Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-saharan Africa. PLoS Med 8: e1000390 doi:10.1371/journal.pmed.1000390.
28. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, et al. (2010) Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 376: 1838-1845.
29. Behforouz HL, Farmer PE, Mukherjee JS, (2004) From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston. Clin Infect Dis 38 (Suppl 5): S429-S436.
30. Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, et al. (2008) Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care 20: 311-317.